Please assess the completion status of the following clinical trial:

Trial Title: Screening for Familial Gastric Cancer in First Degree Relatives

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* adult (≥ 18 yrs), female and male relatives~* fully legal competent (to simplify the common consent agreement for blood withdrawal, DNA analysis and serial endoscopies.)~* individuals that signed the common consent agreement~* first degree relative of an individual with diffuse gastric cancer from a FDGC-family, without proven mutation,~  * OR: 2 or more individuals with gastric carcinoma, at least one \< 50 yrs~ * OR: 3 or more individuals with (diffuse/intestinal/other type) gastric carcinoma, any age~ * OR 1 individual with any type gastric carcinoma \< 40 yrs~Exclusion Criteria:~* immature individuals~* actual gastric ulcer or gastric bleeding~* previous diagnosis of gastric cancer~* hypersensitivity to Indigocarmine~* individuals with co-morbidity which might increase the sedation and/or endoscopy risk: COPD Gold III/IV Cardiac failure Increased bleeding tendency or use of medication which increases bleeding tendency

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Endoscopy without staining of the mucosa (Type: NO_INTERVENTION): None
- Endoscopy with staining of the mucosa. (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).